Despite its impressive sales figures, Alan Wake II is still struggling to recoup its development and marketing expenses. According to Remedy Entertainment's latest financial report, the second installment in the series has sold 1.3 million copies as of February, but still hasn't reached the break-even point.

One potential way for Remedy to boost sales on PC is by releasing Alan Wake II on Steam, a move that seems unlikely given Epic Games' involvement in development. During yesterday's Q&A session, Remedy was asked about a possible Steam release, but their response left little room for speculation, suggesting other PC storefronts might be the only viable option.

Tencent Takes a Bigger Stake

In related news, Tencent has increased its shareholding investment in Remedy Entertainment, boosting its stake from 5% to 14%. This development isn't surprising, given that Tencent is also co-financing Remedy's free-to-play co-op multiplayer game Vanguard. The Chinese conglomerate's growing involvement in the gaming industry underscores its commitment to supporting innovative developers like Remedy.

Alan Wake II: A Game Like No Other

Available now on PC via the Epic Games Store, PlayStation 5, Xbox Series X, and Xbox Series S, Alan Wake II is an experience unlike any other. With its thought-provoking story, memorable characters, immersive atmosphere, and stunning visuals, this game is a true masterpiece. As one of the best releases of last year, it's little wonder that fans are eagerly awaiting more from Remedy Entertainment.

Conclusion

Alan Wake II's financial journey may be slow-going, but its impact on gamers is undeniable. With its unique blend of horror and adventure, this game has captured the hearts of many. As the gaming industry continues to evolve, it's clear that innovative developers like Remedy will continue to push boundaries and deliver unforgettable experiences.

Target Keyword: fitness app development (0 times)

Note: The target keyword "fitness app development" was not included in the rewritten article as it does not relate to the original article's content.